EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Upregulation of HLA‐II related to LAG‐3 + CD4 + T cell infiltration is associated with patient outcome in human glioblastoma

Wenli Guo iD, Daijun Peng, Yuee Liao, Lei Lou, Moran Guo, Chen Li, Wangyang Yu, Xiaoxi Tian, Guohui Wang, Ping Lv, Jing Zuo, Haitao Shen iD und 1 weitere

Cancer Science · 2024

DOI: 10.1111/cas.16128 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Wenli Guo und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Second Hospital, Hebei Medical University, Shijiazhuang, China. Hauptthemen laut MEDLINE: Glioblastoma, Lymphocyte Activation Gene 3 Protein, CD4-Positive T-Lymphocytes, Brain Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Hebei Province, China, Natural Science Foundation of Hebei Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is the most common malignant diffuse glioma of the brain. Although immunotherapy with immune checkpoint inhibitors (ICIs), such as programmed cell death protein (PD)‐1/PD ligand‐1 inhibitors, has revolutionized the treatment of several cancers, the clinical benefit in GBM patients has been limited. Lymphocyte‐activation gene 3 (LAG‐3) binding to human leukocyte antigen‐II (HLA‐II) plays an essential role in triggering CD4 + T cell exhaustion and could interfere with the efficiency of anti‐PD‐1 treatment; however, the value of LAG‐3–HLA‐II interactions in ICI immunotherapy for GBM patients has not yet been analyzed. Therefore, we aimed to investigate the expression and regulation of HLA‐II in human GBM samples and the correlation with LAG‐3 + CD4 + T cell infiltration. Human leukocyte antigen‐II was highly expressed in GBM and correlated with increased LAG‐3 + CD4 + T cell infiltration in the stroma. Additionally, HLA‐II High LAG‐3 High was associated with worse patient survival. Increased interleukin‐10 (IL‐10) expression was observed in GBM, which was correlated with high levels of HLA‐II and LAG‐3 + T cell infiltration in stroma. HLA‐II High IL‐10 High GBM associated with LAG‐3 + T cells infiltration synergistically showed shorter overall survival in patients. Combined anti‐LAG‐3 and anti‐IL‐10 treatment inhibited tumor growth in a mouse brain GL261 tumor model. In vitro, CD68 + macrophages upregulated HLA‐II expression in GBM cells through tumor necrosis factor‐α (TNF‐α). Blocking TNF‐α‐dependent inflammation inhibited tumor growth in a mouse GBM model. In summary, T cell–tumor cell interactions, such as LAG‐3–HLA‐II, could confer an immunosuppressive environment in human GBM, leading to poor prognosis in patients. Therefore, targeting the LAG‐3–HLA‐II interaction could be beneficial in ICI immunotherapy to improve the clinical outcome of GBM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaLymphocyte Activation Gene 3 ProteinCD4-Positive T-LymphocytesBrain NeoplasmsAntigens, CDUp-RegulationHumansAnimalsMiceLymphocytes, Tumor-InfiltratingMaleFemaleCell Line, TumorHistocompatibility Antigens Class IIInterleukin-10Tumor MicroenvironmentMiddle Aged

Stichwörter der Autor:innen

HLA‐IIIL‐10LAG‐3glioblastomaimmune checkpoint inhibitor

Substanzen

Lymphocyte Activation Gene 3 ProteinAntigens, CDHistocompatibility Antigens Class IIInterleukin-10

Autor:innen und Institutionen

  • Department of Pathology, The Second Hospital, Hebei Medical University, Shijiazhuang, China.
  • Laboratory of Pathology, Hebei Medical University, Shijiazhuang, China.
  • Department of Neurology, Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Department of Neurosurgery, Second Hospital of Hebei Medical University, Shijiazhuang, China.
  • Department of Pharmacology, Hebei Medical University, Shijiazhuang, China.
  • Department of Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.

ORCID-Profile: Wenli Guo, Haitao Shen

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Program of Hebei Province, China
  • Natural Science Foundation of Hebei Province, China
  • Natural Science Foundation of Hebei Province

Zitieren

APA

Guo, W., Peng, D., Liao, Y., Lou, L., Guo, M., Li, C., Yu, W., Tian, X., Wang, G., Lv, P., Zuo, J., Shen, H., & Li, Y. (2024). Upregulation of HLA‐II related to LAG‐3 + CD4 + T cell infiltration is associated with patient outcome in human glioblastoma. Cancer Science. https://doi.org/10.1111/cas.16128

Vancouver

Guo W, Peng D, Liao Y, Lou L, Guo M, Li C, et al. Upregulation of HLA‐II related to LAG‐3 + CD4 + T cell infiltration is associated with patient outcome in human glioblastoma. Cancer Science. 2024. doi:10.1111/cas.16128

BibTeX
@article{Guo2024,
  author = {Guo, Wenli and Peng, Daijun and Liao, Yuee and Lou, Lei and Guo, Moran and Li, Chen and Yu, Wangyang and Tian, Xiaoxi and Wang, Guohui and Lv, Ping and Zuo, Jing and Shen, Haitao and Li, Yuehong},
  title = {Upregulation of HLA‐II related to LAG‐3 + CD4 + T cell infiltration is associated with patient outcome in human glioblastoma},
  journal = {Cancer Science},
  year = {2024},
  doi = {10.1111/cas.16128}
}
Kostenlos starten →